NWAM LLC’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,564
| Closed | -$221K | – | 577 |
|
|
2023
Q3 | $221K | Sell |
5,564
-2,557
| -31% | -$102K | 0.02% | 454 |
|
|
2023
Q2 | $333K | Buy |
+8,121
| New | +$333K | 0.03% | 393 |
|
|
2023
Q1 | – | Sell |
-11,962
| Closed | -$490K | – | 559 |
|
|
2022
Q4 | $490K | Buy |
11,962
+340
| +3% | +$13.9K | 0.04% | 314 |
|
|
2022
Q3 | $467K | Sell |
11,622
-271
| -2% | -$10.9K | 0.04% | 303 |
|
|
2022
Q2 | $500K | Buy |
11,893
+145
| +1% | +$6.1K | 0.05% | 302 |
|
|
2022
Q1 | $532K | Buy |
11,748
+122
| +1% | +$5.53K | 0.04% | 318 |
|
|
2021
Q4 | $537K | Buy |
11,626
+769
| +7% | +$35.5K | 0.04% | 318 |
|
|
2021
Q3 | $515K | Sell |
10,857
-20
| -0.2% | -$949 | 0.05% | 317 |
|
|
2021
Q2 | $563K | Sell |
10,877
-5,451
| -33% | -$282K | 0.05% | 290 |
|
|
2021
Q1 | $822K | Sell |
16,328
-106
| -0.6% | -$5.34K | 0.08% | 228 |
|
|
2020
Q4 | $856K | Sell |
16,434
-82
| -0.5% | -$4.27K | 0.1% | 192 |
|
|
2020
Q3 | $718K | Buy |
16,516
+1,165
| +8% | +$50.6K | 0.12% | 146 |
|
|
2020
Q2 | $660K | Buy |
15,351
+62
| +0.4% | +$2.67K | 0.09% | 204 |
|
|
2020
Q1 | $551 | Sell |
15,289
-439
| -3% | -$16 | 0.01% | 217 |
|
|
2019
Q4 | $718K | Buy |
15,728
+633
| +4% | +$28.9K | 0.12% | 174 |
|
|
2019
Q3 | $537K | Sell |
15,095
-1,909
| -11% | -$67.9K | 0.1% | 194 |
|
|
2019
Q2 | $677K | Buy |
17,004
+749
| +5% | +$29.8K | 0.13% | 155 |
|
|
2019
Q1 | $676K | Buy |
+16,255
| New | +$676K | 0.15% | 152 |
|
|
2018
Q4 | – | Sell |
-4,841
| Closed | -$235K | – | 361 |
|
|
2018
Q3 | $235K | Buy |
+4,841
| New | +$235K | 0.05% | 294 |
|